TetraLogic Pharmaceuticals Co. (OTCMKTS:TLOG) Sees Significant Increase in Short Interest

TetraLogic Pharmaceuticals Co. (OTCMKTS:TLOG) was the recipient of a significant increase in short interest in June. As of June 30th, there was short interest totalling 600 shares, an increase of 20.0% from the June 15th total of 500 shares. Based on an average trading volume of 13,300 shares, the days-to-cover ratio is currently 0.0 days.

Shares of OTCMKTS TLOG opened at $0.02 on Thursday. TetraLogic Pharmaceuticals has a 12 month low of $0.01 and a 12 month high of $0.06. The business’s 50-day simple moving average is $0.02.

TetraLogic Pharmaceuticals Company Profile

TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases. It has two clinical-stage product candidates in development, such as birinapant and SHAPE. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases-mimetic, which leads to apoptosis or cell-death in damaged cells.

See Also: Fundamental Analysis and Individual Investors

Receive News & Ratings for TetraLogic Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TetraLogic Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.